GLP-1s Linked to 42% Lower Risk of Anxiety, Depression

• A new study found that people taking GLP-1 drugs like Ozempic and Wegovy had a lower risk of worsening depression and anxiety.
• The participants also had fewer hospitalizations and required less sick leave from their jobs.
• Experts say the drugs’ effects on dopamine signaling and brain inflammation could account for the benefits.
• It’s too soon to recommend GLP-1s as a primary treatment for mental health disorders. Further clinical trials are still needed.

Researchers say people living with diabetes often face a higher risk of developing mental health conditions.

Now, a large national study from Sweden found that certain medications commonly prescribed…